학술논문

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
Document Type
Article
Source
The Lancet Diabetes & Endocrinology; September 2022, Vol. 10 Issue: 9 p645-654, 10p
Subject
Language
ISSN
22138587; 22138595
Abstract
Controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. We aimed to investigate the effects of blood pressure-lowering treatment on the risk of major cardiovascular events by type 2 diabetes status, as well as by baseline levels of systolic blood pressure.